亚临床甲状腺功能障碍与骨质疏松的关系及研究进展  

The Relationship and Research Progress be-tween Subclinical Thyroid Dysfunction and Osteoporosis

作　　者：杨贤 杨历新[2] 

机构地区：[1]青海大学研究生院,青海 西宁 [2]青海省人民医院内分泌科,青海 西宁

出　　处：《临床医学进展》2023年第6期10124-10129,共6页Advances in Clinical Medicine

摘　　要：亚临床甲状腺功能减退、亚临床甲状腺功能亢进与骨质疏松均是临床中的常见性和多发性疾病。甲状腺激素在发育期、儿童期和成人期几乎所有组织中发挥广泛而复杂的作用。甲状腺激素是骨骼发育和骨代谢所必需的,是骨骼维持的重要调节剂。当亚临床甲状腺功能障碍时,甲状腺激素和促甲状腺激素水平异常,从而可能会增加骨量减少、骨质疏松,甚或骨折的风险。本文对亚临床甲状腺功能障碍与骨质疏松的关系及研究进展进行综述。Subclinical hypothyroidism, subclinical hyperthyroidism, and osteoporosis are common and multi-ple diseases in clinical practice. Thyroid hormone plays an extensive and complex role in almost all tissues during development, childhood and adulthood. Thyroid hormone is necessary for bone de-velopment and bone metabolism, and is an important regulator of bone maintenance. When sub-clinical thyroid dysfunction occurs, the levels of thyroid hormone and thyroid stimulating hormone are abnormal, which may increase the risk of osteopenia, osteoporosis, or even fracture. This article reviews the relationship and research progress between subclinical thyroid dysfunction and osteo-porosis.

关 键 词：亚临床甲状腺功能减退 亚临床甲状腺功能亢进 骨质疏松 

分 类 号：R73[医药卫生—肿瘤]